Thanks to mass immunization campaigns, by the year 2000, measles, once a common childhood illness with severe complications, ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

The respiratory syncytial virus (RSV) vaccine (Abrysvo) was linked with fewer hospitalizations and emergency department (ED) ...

By restricting access to just one vaccine today, as has happened in the past through political wrangling, we risk repeating ...

As the US Supreme Court begins its 2024–25 term, the possibility looms that it might put yet another consequential case on ...

Recent research indicates that vaccination recommendations by the ACIP and CDC, have been credited to preventing millions of ...

In a report released yesterday, Graham Parry from Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), ...

The U.S. Food and Drug Administration (FDA) has updated the label for FLUBLOK (Influenza Vaccine) to include data from a new safety study involving pregnant individuals 18 years and older, in time to ...

Dynavax (DVAX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Edward White from ...

A panel at the Centers for Disease Control and Prevention (CDC) that advises the U.S. government on vaccine policy is ...

In 2023, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) recommended adults 65 years and older get a single dose of the respiratory syncytial virus ...

Researchers are learning more about enhanced flu vaccines. Learn what the latest findings show, how available the vaccines are, and who should consider getting one.